Gietema JA

Gietema JA

Rijksuniversiteit Groningen

H-index: 71

Europe-Netherlands

About Gietema JA

Gietema JA, With an exceptional h-index of 71 and a recent h-index of 47 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen, specializes in the field of Testicular cancer, cancer survivorship care, early clinical trials with molecular imaging.

His recent articles reflect a diverse array of research interests and contributions to the field:

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

Change in telomere length and cardiovascular risk factors in testicular cancer survivors

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium

Abstract CT064: Impact of food and high gastric pH on the bioavailability of the WEE1 inhibitor Debio 0123 assessed in a phase 1 dose escalation study

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer, a prospective randomized study (Bullseye)

LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy

132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN–an EORTC-SPECTA and EURACAN study

Predictors of adherence to exercise interventions

Gietema JA Information

University

Position

Professor of Medical Oncology, University Medical Center Groningen

Citations(all)

18390

Citations(since 2020)

7908

Cited By

13850

hIndex(all)

71

hIndex(since 2020)

47

i10Index(all)

205

i10Index(since 2020)

146

Email

University Profile Page

Rijksuniversiteit Groningen

Google Scholar

View Google Scholar Profile

Gietema JA Skills & Research Interests

Testicular cancer

cancer survivorship care

early clinical trials with molecular imaging

Top articles of Gietema JA

Title

Journal

Author(s)

Publication Date

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

Jean-Yves Blay

Paolo Casali

Isabelle Ray-Coquard

Michael J Seckl

Jourik Gietema

...

2024/4/1

Change in telomere length and cardiovascular risk factors in testicular cancer survivors

Urologic Oncology: Seminars and Original Investigations

Ellen LD Volders

Coby Meijer

Lotte S Steeneken

Sjoukje Lubberts

Nynke Zwart

...

2024/1/1

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium

European Journal of Cancer

Emanuel Bührer

David D'Haese

Gedske Daugaard

Ronald de Wit

Costantine Albany

...

2024/5/1

Abstract CT064: Impact of food and high gastric pH on the bioavailability of the WEE1 inhibitor Debio 0123 assessed in a phase 1 dose escalation study

Cancer Research

Anne Bellon

Omar Saavedra

Ingrid M Desar

Mathilde Jalving

Jourik A Gietema

...

2024/4/5

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer, a prospective randomized study (Bullseye)

Nuklearmedizin-NuclearMedicine

BM Prive

CH Muselaers

D Meijer

WA van Gemert

BJ Timmermans

...

2024/4

LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy

Cancer Research

Pim P van de Donk

Lotte M Smit

Joyce van Sluis

Wim Timens

Adrienne H Brouwers

...

2023/4/4

132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN–an EORTC-SPECTA and EURACAN study

Annals of Oncology

M Morfouace

J Oliveira

N Penel

J Peron

M Pracht

...

2023/10/1

Predictors of adherence to exercise interventions

Center Groningen, at the Department of Medical Oncology, Groningen, the Netherlands. The research project was funded by the Junior Scientific Masterclass, University of Groningen. Part of the studies in this thesis were funded by the Dutch Cancer Society,

Harm L Ormel

Gabriela GF van der Schoot

Wim J Sluiter

Hilde Jalving

Jourik A Gietema

...

2023

Langetermijneffecten van de behandeling van patiënten met testiskanker: implicaties voor nazorg en follow-up

Tijdschrift voor Urologie

Sjoukje Lubberts

Jourik A Gietema

2023/10

Self-monitoring physical activity with a smartphone application in cancer patients: a randomized

Supportive care in cancer

Harm L Ormel

Gabriela GF van der Schoot

Nico-Derk L Westerink

Wim J Sluiter

Jourik A Gietema

...

2018/11

Cardiovascular disease in testicular cancer survivors: identification of risk factors and impact on quality of life

Journal of Clinical Oncology

Sjoukje Lubberts

Harmke J Groot

Ronald de Wit

Sasja Mulder

Johannes A Witjes

...

2023/7/7

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory …

Journal of cancer research and clinical oncology

Gabriela GF van der Schoot

Harm L Ormel

Nico-Derk L Westerink

Johan B Wempe

Joop D Lefrandt

...

2023/12

4.8. 4. e Malignant Germ-Cell Tumours of the Adult Male.

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023

Jourik A Gietema

Christian Kollmannsberger

2023

Debio 0123-101: a phase 1 trial of debio 0123 in combination with carboplatin in advanced solid tumors—safety, pharmacokinetic, and preliminary antitumor activity data

J Clin Oncol

Hans Gelderblom

Mathilde Jalving

Ingrid Desar

Omar Saavedra

Jourik A Gietema

...

2023/6/1

Reply to G. Wang et al

Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology

Eun Hyo Jin

Kyungdo Han

Cheol Min Shin

2023/10/2

Evaluation of senescence and its prevention in doxorubicin-induced cardiotoxicity using dynamic engineered heart tissues

Cardio Oncology

Annet N Linders

Itamar B Dias

Ekaterina S Ovchinnikova

Mathilde CSC Vermeer

Martijn F Hoes

...

2023/6/1

737P Vascular fingerprint tool to identify testicular cancer patients at high-risk for early cardiovascular events after cisplatin-based chemotherapy

Annals of Oncology

AT Meuleman

E Volders

S Lubberts

JM Kerst

M Wymenga

...

2023/10/1

Shared-care survivorship program for testicular cancer patients: safe and feasible

ESMO open

H Boer

S Lubberts

S Bunskoek

J Nuver

JD Lefrandt

...

2022/6/1

Optimal timing of a physical exercise intervention to improve cardiorespiratory fitness: during or after chemotherapy

Cardio Oncology

Gabriela GF van der Schoot

Harm L Ormel

Nico-Derk L Westerink

Anne M May

Sjoerd G Elias

...

2022/11/1

Physical activity and cardiac function in long-term breast cancer survivors: a cross-sectional study

Cardio Oncology

Willeke R Naaktgeboren

Wim G Groen

Judy N Jacobse

Lars C Steggink

Annemiek ME Walenkamp

...

2022/6/1

See List of Professors in Gietema JA University(Rijksuniversiteit Groningen)